TREATMENT OF DEMYELINATING DISORDERS WITH SOLUBLE LYMPHOTOXIN-BETA-RECEPTOR
- 专利权人:
- Jeffrey L. BROWNING;Jenny P-Y TING
- 发明人:
- Jeffrey L. BROWNING,Jenny P-Y TING
- 申请号：
- US13275629
- 公开号：
- US20120244153A1
- 申请日:
- 2011.10.18
- 申请国别(地区):
- US
- 年份:
- 2012
- 代理人:
- 摘要：
- The invention relates to the treatment of demyelinating disorders, e.g. multiple sclerosis, using a soluble lymphotoxin beta receptor (LTβR) as an inhibitor of the lymphotoxin pathway.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Treatment of Demyelinating Disorders with Soluble Lymphotoxin-Beta-Receptor
- TREATMENT OF DEMYELINATING DISORDERS WITH SOLUBLE LYMPHOTOXIN-BETA-RECEPTOR
- COMBINATION OF TGF-.BETA. INHIBITION AND IMMUNE STIMULATION TO TREAT HYPERPROLIFERATIVE DISEASES
- Combinations and Methods for Treating Inflammatory Bowel Disease Using a Combination Therapy of Small Molecule Inhibitors of C-C Chemokine Receptor 9 (CCR9) and Anti-alpha4beta7 Integrin Blocking Antibodies
- Traitement de maladies démyélinisantes avec le recepteur soluble de la lymphotoxine beta
